Patent ID: 7973080

Claim:
A method of inhibiting the growth of multiple-resistant bacteria comprising topical administration of a pharmaceutical composition comprising 15% by weight or more of pentane-1,5-diol as multiple-resistant bacteria bacteriostatic agent and a pharmaceutical acceptable carrier, wherein said composition is essentially free of a bacteriostatic agent other than pentane-1,5-diol, and wherein the multiple-resistant bacteria is at least one member of the group consisting of Staphylococcus aureus resistant to methicillin or fucidic acid, coagulation-negative staphylococci resistant to fucidic acid, Enterococcus resistant to fucidic acid, vancomycin, ciprofloxacin or trimetoprim, Acinetobacter resistant to cefadroxil, nitrofurantin or mecillinam, Pseudomonas aeruginosa resistant to vancomycin, ciprofloxacin or trimetoprim, and trimetoprin resistant E. coli.